Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Interest Expenses (2016 - 2022)

Arcadia Biosciences' Interest Expenses history spans 8 years, with the latest figure at $1000.0 for Q1 2022.

  • For Q1 2022, Interest Expenses fell 88.89% year-over-year to $1000.0; the TTM value through Dec 2022 reached $1000.0, down 95.45%, while the annual FY2021 figure was $20000.0, 57.45% down from the prior year.
  • Interest Expenses reached $1000.0 in Q1 2022 per RKDA's latest filing, up from -$3000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $23000.0 in Q3 2020 to a low of -$3000.0 in Q4 2021.
  • Average Interest Expenses over 4 years is $6818.2, with a median of $3000.0 recorded in 2019.
  • Peak YoY movement for Interest Expenses: soared 666.67% in 2020, then tumbled 120.0% in 2021.
  • A 4-year view of Interest Expenses shows it stood at $2000.0 in 2019, then soared by 650.0% to $15000.0 in 2020, then tumbled by 120.0% to -$3000.0 in 2021, then surged by 133.33% to $1000.0 in 2022.
  • Per Business Quant, the three most recent readings for RKDA's Interest Expenses are $1000.0 (Q1 2022), -$3000.0 (Q4 2021), and $15000.0 (Q3 2021).